Board of Directors

Lindsay P Ralphs

Lindsay Ralphs

CA (SA)
Chairman of the Board
Appointed: 1 July 2019

CEO of The Bidvest Group Limited since May 2016. Director of numerous Bidvest subsidiaries, Chairman of Bidvest South Africa divisions and Chairman of Bidvest Namibia. Previously served on the board of Adcock Ingram Holdings Limited.

Previous experience

  • CEO of Bidvest South Africa
  • Formed the Bidvest Services division
  • Managing Director of Bidvest Steiner
Andrew G Hall

Andrew G Hall

CA (SA), BPharm
Chief Executive Officer
Appointed: 15 July 2008

Oversees Group Finance, Business Development, Investor Relations, and the Legal and Company Secretariat. Joined Adcock Ingram in 2007 as Chief Financial Officer.

Previous experience

  • Deputy Chief executive and Financial Director at Adcock Ingram
  • Partner in charge of health sciences at Ernst & Young
  • CFO of a listed pharmaceutical company in South Africa
  • Sales and marketing at Pfizer, and retail pharmacy
Dorette Neethling

Dorette Neethling

CA (SA), MCom (Taxation)
Chief Financial Officer
Appointed: 23 February 2016

Joined Adcock Ingram in August 2007 as Group Finance Executive

Previous experience

  • Financial Director at Quintiles South Africa
  • Financial Manager in FMCG environment in Namibia
  • Currently serves as member of the Financial Reporting Investigation Panel (FRIP)
Lulama Boyce

Lulama Boyce

CA (SA), BCom (Hons)
Independent non-executive director
Appointed: 23 May 2017

Senior lecturer and subject head in the commercial accounting department at the University of Johannesburg. Independent non-executive director on the boards of Coronation Fund Managers Limited, Coronation Management Company (RF) Proprietary Limited and Coronation Life Assurance Company Limited.

Previous experience

  • Financial and consulting experience in both the private and public sectors
  • Account manager of the Industrial Development Corporation
  • Project finance consultant
Sibongile Gumbi

Dr Sibongile Gumbi

PhD in Pharmacology, MBA
Independent non-executive director
Appointed: 13 August 2019

Founder and CEO of iVacBio

Previous experience

  • Fellow of the eighth class of the African Leadership Initiative and a member of its associated Global Leadership Network.
  • Sibongile is a specialist in technology and innovation management having worked in several leadership positions for local and international organisations concerned with science, technology and innovation.
Matthias Haus

Matthias Haus

MB ChB, MD, DCH, FCFP, FFPM, Dip Obst
Lead Independent Director
Appointed: 1 July 2019

Adjunct Professor in Medicine, University of Cape Town. Extraordinary Professor in Medicine, University of Pretoria. Partner at Gateways Business Consulting Group. Trustee of the Colleges of Medicine of South Africa. Editor in chief at Current Allergology and Clinical Immunology. Executive at the Allergy Society of South Africa.

Previous experience

  • Executive Vice President, AstraZeneca (sub-Saharan Africa and China)
  • Non-executive chairman, Professional Provident Society of South Africa
  • Senator, Colleges of Medicine of South Africa
Basadi Letsoalo

Basadi Letsoalo

MPsych , CLDP, MLPC
Executive Director – Transformation and Human Capital
Appointed: 25 August 2016

Responsible for Human Capital strategy and implementation, labour relations and executive remuneration. Leads transformation strategy and B-BBEE implementation. Joined Adcock Ingram in January 2008 as Group Human Capital Executive.

Previous experience

  • Head of Transformation at Standard Bank SA
  • Head of HR information management at ABSA
  • Currently serves as a member of the University of KwaZulu-Natal Council
  • Also a non-executive director at NMG Consultants and Actuaries, and Ad-Izinyosi Proprietary Limited, as well as a trustee of the Mpho ea Bophelo Trust
Nompumelelo Madisa

Nompumelelo Madisa

Master’s Degree in Finance and Investment - Wits
Non-independent non-executive director
Appointed: 23 November 2017

Executive Director of the Bidvest Group Limited. Member of various Board Committees. Director of numerous Bidvest subsidiaries.

Previous experience

  • Various senior positions within the Bidvest Group of companies since 2008
  • Experience in the public sector
Dr Claudia Manning

Dr Claudia Manning

PhD
Independent non-executive director
Appointed: 24 November 2016

Non-executive director of Basil Read Holdings, Mondi Zimele Pty Limited, Sangena Investment Pty Limited and MSC Educational Holdings. Obtained a doctorate in development studies from the University of Sussex, UK.

Previous experience

  • Project finance role at Development Bank of Southern Africa (DBSA)
  • Co-founder of Investment and consulting company
  • Experience in advising on infrastructure Public Private Partnerships (PPPs)
  • MD of Southern African arm of global development consultancy
Debbie Ransby

Debbie Ransby

CA (SA), member of the Institute of Directors, Executive Business Coach
Independent non-executive director
Appointed: 13 August 2019

Founder of Connected Coaching (Pty) Ltd

Previous experience

  • Finance, Supply Chain and Administration at GlaxoSmithKline (GSK).
  • Fulfilled the role of Finance Director at Takeda (formerly Nycomed) before serving as Managing Director.
Michael Sathekge

Professor Michael Sathekge

MB., ChB.(Medunsa), M. Med (Nuclear Medicine), PhD (Ghent, Belgium), FAMS (Singapore Academy of Medicine), Elected Member of the Academy of Science of South Africa: MASSAf, Programme for Academic Leadership (GIBS), NRF Rated: International Acclaimed Researcher
Independent non-executive director
Appointed: 25 August 2020

Professor and Head of Department of Nuclear Medicine at the University of Pretoria and Steve Biko Academic Hospital. Editors in Chief of the Seminars of Nuclear Medicine Journal. Editor for the Image of the Month for European Journal of Nuclear Medicine and Molecular Imaging. Associate Editor of The World Journal of Nuclear Medicine. Chairman and Director of Nuclear Medicine Research Infrastructure. President-Elect of the World Association of Radiopharmaceuticals and Molecular Therapy.


Previous experience

  • Chairman of the Medical Research Council Board
  • President of the Colleges of Medicine of South Africa
  • President of International Society of Radiolabeled Blood Elements
  • Chairman of Technical & Investment Committee: Board of Nuclear Technology Products
Kevin Wakeford

Kevin Wakeford

CA (SA)
Non-independent non-executive director
Appointed: 27 August 2019

Chief Executive Officer: Bidvest Office & Print

Previous experience

  • South African Breweries Limited
  • Operations Director: Southern Sun Hotels
  • Chief Executive Officer: Bidvest Travel & Aviation
  • Chief Executive Officer: Adcock Ingram (April 2014 to November 2015)